Advertisement
Review Article| Volume 35, ISSUE 4, P765-778, December 2015

Clinical Manifestations and Treatment of Lyme Disease

Published:September 24, 2015DOI:https://doi.org/10.1016/j.cll.2015.08.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. C.f.D.C.a.P. Reported cases of Lyme disease by year, United States, 1995–2013. 2015. Available at: http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html. Accessed September 16, 2015.

        • Steere A.C.
        • Sikand V.K.
        • Schoen R.T.
        • et al.
        Asymptomatic infection with Borrelia burgdorferi.
        Clin Infect Dis. 2003; 37: 528-532
        • Steere A.C.
        Lyme disease (Lyme Borreliosis) due to Borrelia burgdorferi.
        in: Dolin R. Bennett J.E. Blaser M.J. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Saunders, Philadelphia2015: 2725-2735
        • Nadelman R.B.
        • Nowakowski J.
        • Forseter G.
        • et al.
        The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
        Am J Med. 1996; 100: 502-508
        • Strle F.
        • Nadelman R.B.
        • Cimperman J.
        • et al.
        Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.
        Ann Intern Med. 1999; 130: 32-36
        • Steere A.C.
        • Sikand V.K.
        The presenting manifestations of Lyme disease and the outcomes of treatment.
        N Engl J Med. 2003; 348: 2472-2474
        • Shapiro E.D.
        Lyme disease.
        N Engl J Med. 2014; 371: 684
        • Pachner A.R.
        • Steere A.C.
        The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.
        Neurology. 1985; 35: 47-53
        • Halperin J.J.
        Nervous system lyme disease.
        Clin Lab Med. 2015; (in press)
        • Peeters N.
        • van der Kolk B.Y.
        • Thijsen S.F.
        • et al.
        Lyme disease associated with sudden sensorineural hearing loss: case report and literature review.
        Otol Neurotol. 2013; 34: 832-837
        • Fish A.E.
        • Pride Y.B.
        • Pinto D.S.
        Lyme carditis.
        Infect Dis Clin North Am. 2008; 22 (vi): 275-288
        • Steere A.C.
        • Schoen R.T.
        • Taylor E.
        The clinical evolution of Lyme arthritis.
        Ann Intern Med. 1987; 107: 725-731
        • Steere A.C.
        • Klitz W.
        • Drouin E.E.
        • et al.
        Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.
        J Exp Med. 2006; 203: 961-971
        • Stanek G.
        • Strle F.
        Lyme borreliosis.
        Lancet. 2003; 362: 1639-1647
        • Asbrink E.
        • Hovmark A.
        • Olsson I.
        Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients.
        Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263: 253-261
        • Feder Jr., H.M.
        • Johnson B.J.
        • O'Connell S.
        • et al.
        A critical appraisal of “chronic Lyme disease”.
        N Engl J Med. 2007; 357: 1422-1430
        • Klempner M.S.
        • Hu L.T.
        • Evans J.
        • et al.
        Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
        N Engl J Med. 2001; 345: 85-92
        • Krupp L.B.
        • Hyman L.G.
        • Grimson R.
        • et al.
        Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
        Neurology. 2003; 60: 1923-1930
        • Kaplan R.F.
        • Trevino R.P.
        • Johnson G.M.
        • et al.
        Cognitive function in post-treatment Lyme disease: do additional antibiotics help?.
        Neurology. 2003; 60: 1916-1922
        • MacDonald A.B.
        Human fetal borreliosis, toxemia of pregnancy, and fetal death.
        Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263: 189-200
        • Markowitz L.E.
        • Steere A.C.
        • Benach J.L.
        • et al.
        Lyme disease during pregnancy.
        JAMA. 1986; 255: 3394-3396
        • Schlesinger P.A.
        • Duray P.H.
        • Burke B.A.
        • et al.
        Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi.
        Ann Intern Med. 1985; 103: 67-68
        • Maraspin V.
        • Cimperman J.
        • Lotric-Furlan S.
        • et al.
        Erythema migrans in pregnancy.
        Wien Klin Wochenschr. 1999; 111: 933-940
        • Lakos A.
        • Solymosi N.
        Maternal Lyme borreliosis and pregnancy outcome.
        Int J Infect Dis. 2010; 14: e494-e498
        • Nadelman R.B.
        • Hanincová K.
        • Mukherjee P.
        • et al.
        Differentiation of reinfection from relapse in recurrent Lyme disease.
        N Engl J Med. 2012; 367: 1883-1890
        • Wormser G.P.
        • Masters E.
        • Nowakowski J.
        • et al.
        Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.
        Clin Infect Dis. 2005; 41: 958-965
        • Morgan M.
        • Nathwani D.
        Facial palsy and infection: the unfolding story.
        Clin Infect Dis. 1992; 14: 263-271
        • Wormser G.P.
        • Dattwyler R.J.
        • Shapiro E.D.
        • et al.
        The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.
        Clin Infect Dis. 2006; 43: 1089-1134
        • Dever L.L.
        • Jorgensen J.H.
        • Barbour A.G.
        In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
        J Clin Microbiol. 1992; 30: 2692-2697
        • Wormser G.P.
        • Ramanathan R.
        • Nowakowski J.
        • et al.
        Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
        Ann Intern Med. 2003; 138: 697-704
        • Dattwyler R.J.
        • Luft B.J.
        • Kunkel M.J.
        • et al.
        Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
        N Engl J Med. 1997; 337: 289-294
        • Karlsson M.
        • Hammers-Berggren S.
        • Lindquist L.
        • et al.
        Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.
        Neurology. 1994; 44: 1203-1207
        • Ljostad U.
        • Skogvoll E.
        • Eikeland R.
        • et al.
        Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
        Lancet Neurol. 2008; 7: 690-695
        • Donta S.T.
        Macrolide therapy of chronic Lyme disease.
        Med Sci Monit. 2003; 9: PI136-PI142
        • Donta S.T.
        Tetracycline therapy for chronic Lyme disease.
        Clin Infect Dis. 1997; 25: S52-S56
        • Fallon B.A.
        • Tager F.
        • Fein L.
        • et al.
        Repeated antibiotic treatment in chronic Lyme disease.
        J Spirochetal Tick-Borne Dis. 1999; 5: 94-102
        • Girschick H.J.
        • Guilherme L.
        • Inman R.D.
        • et al.
        Bacterial triggers and autoimmune rheumatic diseases.
        Clin Exp Rheumatol. 2008; 26: S12-S17